GNH USA

Europe — EMA

Noradrenalin Fresenius Kabi (Noradrenaline Tartrate)

GNH USA supplies Noradrenalin Fresenius Kabi (Noradrenaline Tartrate), a sympathomimetic vasopressor for acute hypotension, septic shock, cardiac arrest

Noradrenaline Tartrate

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Noradrenaline Tartrate, the active ingredient in Noradrenalin Fresenius Kabi, is a sympathomimetic (vasopressor) presented as an injection solution for intravenous use. It treats acute hypotension, septic shock, cardiac arrest and postoperative hypotension in hospitalized patients.

GNH USA supplies Noradrenalin Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Noradrenaline Tartrate used for?

Noradrenalin is a sympathomimetic vasopressor used in critical‑care settings to support circulatory function.

Acute hypotension: restores systemic blood pressure when rapid support is needed. Septic shock: maintains perfusion pressure during severe infection‑related vasodilation. Cardiac arrest: improves coronary and cerebral perfusion during resuscitation. Post‑operative hypotension: stabilises hemodynamics after surgery.

What are the side effects of Noradrenaline Tartrate?

Adverse reactions may range from mild to life‑threatening and should be monitored during infusion.

Common Side Effects: - Tachycardia: increased heart rate due to beta‑1 activity. - Hypertension: excessive rise in blood pressure. - Peripheral ischemia: reduced blood flow to extremities. - Headache: secondary to vascular changes. - Nausea: gastrointestinal upset. - Arrhythmia: irregular heart rhythm.

Serious or Rare Side Effects: - Myocardial ischemia: reduced coronary perfusion. - Tissue necrosis at infusion site: extravasation injury. - Severe hypertension: dangerous pressure spikes. - Life‑threatening arrhythmias: ventricular tachycardia or fibrillation. - Anaphylaxis: acute allergic reaction. - Limb gangrene: extreme peripheral ischemia.

What precautions apply to Noradrenaline Tartrate?

Noradrenalin requires careful monitoring and specific handling to minimise risk.

Dose titration: adjust infusion rate based on real‑time blood pressure response. Cardiac monitoring: continuous ECG and hemodynamic surveillance are essential. Extravasation risk: inspect infusion site frequently for signs of tissue injury. Use with caution in patients with pre‑existing arrhythmias: may exacerbate rhythm disturbances. Avoid rapid bolus administration: can cause abrupt hypertension. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Noradrenaline Tartrate interact with?

Noradrenalin can interact with several drug classes, influencing cardiovascular stability.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive vasoconstriction may precipitate severe hypertension. - Beta‑blockers: may blunt beta‑1 mediated cardiac output increase.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive response if dosing is insufficient. - Calcium channel blockers: additive effects on vascular tone. - General anesthetics: may potentiate hemodynamic instability during surgery.

Frequently asked questions

What conditions is Noradrenalin Fresenius Kabi used for?+
Noradrenalin Fresenius Kabi is indicated for the rapid treatment of acute hypotension, septic shock, cardiac arrest, and postoperative hypotension. It is administered in critical‑care environments to restore and maintain adequate blood pressure and organ perfusion.
How does Noradrenaline Tartrate work in the body?+
Noradrenaline Tartrate acts as a direct agonist at alpha‑1 adrenergic receptors, causing strong vasoconstriction that raises systemic vascular resistance. It also stimulates beta‑1 receptors modestly, increasing heart contractility and cardiac output, together supporting circulatory pressure in shock states.
What is the usual dose of Noradrenalin Fresenius Kabi?+
The dosing regimen for Noradrenalin Fresenius Kabi is determined by the prescribing clinician based on the patient’s hemodynamic status, target blood pressure, and response to therapy. Dosage is individualized and titrated during continuous intravenous infusion.
Is Noradrenalin safe to use during pregnancy or breastfeeding?+
Safety data for Noradrenaline Tartrate in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Noradrenalin Fresenius Kabi from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.
How does Noradrenalin compare with other vasopressors?+
Noradrenalin is the first‑line vasopressor for most shock states because of its potent alpha‑1 mediated vasoconstriction and modest beta‑1 activity. Compared with agents such as dopamine or phenylephrine, it provides more predictable blood pressure control with fewer tachyarrhythmic effects, making it the preferred choice in many guidelines.
What are the storage and handling requirements for this product?+
Noradrenalin Fresenius Kabi must be stored at 2‑8 °C, protected from light, and never frozen. The vial should be kept in its original packaging, and the solution should not be shaken. Once removed from refrigeration, it should be used promptly according to the manufacturer’s stability instructions.
How is Noradrenalin administered to patients?+
The medication is supplied as an injectable solution for intravenous infusion. It is typically diluted in a compatible carrier fluid and administered via a calibrated infusion pump, allowing precise titration of the infusion rate to achieve the desired hemodynamic response.
What are the most serious risks associated with Noradrenalin use?+
Serious risks include severe hypertension, myocardial ischemia, life‑threatening arrhythmias, tissue necrosis from extravasation, and rare cases of anaphylaxis. Continuous cardiovascular monitoring is essential to detect and manage these complications promptly.
Who should not receive Noradrenalin Fresenius Kabi?+
Patients with known hypersensitivity to noradrenaline or any excipients in the formulation should not receive the drug. Caution is also advised in individuals with uncontrolled arrhythmias, severe peripheral vascular disease, or those taking monoamine oxidase inhibitors, where the risk of adverse events is heightened.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Fresenius Kabi Ab
Origin
EU

Related products

Cronomir

Cronomir

Noradrenaline Tartrate

Laboratoire Aguettant
EU
L-Noradrenalina Braun

L-Noradrenalina Braun

Noradrenaline Tartrate

B. Braun Medical Lda.
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU